PEP-Therapy

We are #recruiting a R&D trainee to work on the development of our lead product, PEP-010. Check out the internship offer and do not hesitate to apply! #oncology #biotech #peptides #apoptosis #labwork

📢 We are pleased to announce the publication of a paper highlighting our translational study in Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, Elsevier, showing that our lead product, PEP-010, currently evaluated in a Phase Ib #clinicaltrial, induces #apoptosis in #cancer cells, which can be monitored by pharmacodynamic #biomarkers. The paper is available in Open Access, DOI https://lnkd.in/eHRyHu2A. 👏 Congratulations to all authors, Diego Germini, Rayan FARHAT, Laura Dadon, Aline LACROIX, Fariba NEMATI, Angelita Rebollo, Didier Decaudin, Joëlle Wiels and Catherine Brenner as well as the entire PEP-Therapy team.   #peptides #oncology #biotech #achievement

We are thrilled to announce the publication of our work in Frontiers in Pharmacology, showing that our lead product, PEP-010, currently evaluated in a Phase Ib #clinicaltrial, is effective in monotherapy and in combination with paclitaxel in resistant ovarian adenocarcinoma. The paper is available in Open Access, DOI 10.3389/fphar.2024.1444973.   Congratulations to all authors, Aline LACROIX, Rayan FARHAT, Aude ROBERT, Catherine Brenner, Joëlle Wiels and Diego Germini, as well as the entire PEP-Therapy team.   #peptides #oncology #ovarian #cancer #achievement

We are #recruiting a Regulatory Affairs & Market Access Officer to work on the development of our lead product, PEP-010. Check out the job offer and do not hesitate to apply! #oncology #biotech #peptides #clinicaltrials #marketaccess #regulatory

We are happy to share updates on our PEP-010 program at the European Association for Cancer Research (EACR) Annual Meeting which will be held June 10-13 in Rotterdam, Netherlands. Come and visit our posters or ping Diego Germini or Jennifer Sengenès if you want more information!   Title Poster 1: PP2A triggers the cell death signaling cascade after treatment with PEP-010, a first-in-class clinical-stage pro-apoptotic peptide Abstract Number: 0252 Session: Experimental/Molecular Therapeutics, Pharmacogenomics   Title Poster 2: PEP-010, a first-in-class clinical-stage pro-apoptotic peptide is efficient in vitro and in ovo on pancreatic cancer in monotherapy and in combination with different chemotherapies Abstract Number: 0302 Session: Translational Research   Session Date and Time: June 11, 2024, 11:00 AM – 8:15 PM Venue: Rotterdam Ahoy, Rotterdam, Netherlands, Poster and Exhibition Hall   #EACR2024 #oncology #pancreas #apoptosis #peptides #biotech

We are happy to welcome Hatem Azim as Chief Medical Officer of PEP-Therapy !   Hatem is a seasoned drug developer and brings more than 20 years of healthcare and biotech or pharmaceutical industry experience, having led the advancement of about fifteen of early to late-stage clinical drug development programs in oncology.   #oncology #cancers #clinicaltrials #peptides #biotech #cmo

We are excited to announce with Institut Curie that the first patients have been dosed in the Phase Ib clinical trial evaluating our lead candidate PEP-010 in #ovarian and #pancreatic cancers. #oncology #clinicaltrials #peptides #biotech

[#INTERNATIONAL] 🚀 Medicen Paris Region et Spartners by Servier France & BioLabs France ont le plaisir de vous annoncer les lauréats du Bio Partnering Pass Challenge. 👏 Bravo à : 📌 Rosetta Omics 📌 Altevax Biotech 📌 Persea 📌 WhiteLab Genomics 📌 PEP-Therapy 🎫 Ces start-ups formeront la délégation de cinq entreprises franciliennes pour participer à Bio USA 2024, un événement majeur dans le secteur de la biotechnologie qui se tiendra à San Diego du 3 au 6 juin 2024. Sophie de Ferrières Wahid Awad, Ph.D. MBA Timothé CYNOBER (Pharm D.) Julien Cottineau David Del Bourgo Jennifer Sengenès Antoine PRESTAT Michael Heim Hélène Sire Celine Triquel Elodie Thierion Silvia Paolella Kévin PLOUCHART Olivia Dollin Yann Masson Anais Ralimbimanana Irene Blat, PhD Danielle Bogdanowicz

Nous #recrutons un(e) Assitant(e) administratif. N'hésitez pas à postuler ! #hiring #officemanager #biotech